Pairing the expansive knowledge and technical talent of our team with available and scalable capacity means that we can accelerate your journey from bench-to-clinic helping you deliver life-changing therapeutics to patients.
Delivering larger batches with greater consistency and reliability, we support you with the latest technologies from a state-of-the-art facility that is designed with the aseptic manufacture of retrovirus vectors in mind. Our established platform utilizes single-use technology and optimized closed and semi-automated processes for robust, efficient viral vector production.
Simplifying and de-risking your development and scale-up, we deliver a full suite of complementary process development capabilities to support cGMP and commercial readiness, upstream and downstream process improvements, research-grade and preclinical vector production, and analytical assay development and validation from the site. We develop producer cell lines that not only allow consistency and scalability but reduce future costs.
Analytical testing services, including vector stability testing, and safety and sterility testing, are also available.
Scalable and Consistent Manufacturing
We support you in developing robust, scalable, and efficient processes to help you realize the potential of your therapy.Read more
Leverage our world-class partnerships, streamline your production, and advance your cell therapy to trial and beyond.Read more